{"id":20731,"date":"2024-08-15T21:47:19","date_gmt":"2024-08-15T18:47:19","guid":{"rendered":"https:\/\/www.livzym.com\/?p=20731"},"modified":"2025-02-24T15:26:56","modified_gmt":"2025-02-24T12:26:56","slug":"biyoteknolojide-yerli-uretime-stratejik-yatirim","status":"publish","type":"post","link":"https:\/\/www.livzym.com\/index.php\/2024\/08\/15\/biyoteknolojide-yerli-uretime-stratejik-yatirim\/","title":{"rendered":"Biyoteknolojide Yerli \u00dcretime Stratejik Yat\u0131r\u0131m"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_type=&#8221;row&#8221; use_row_as_full_screen_section=&#8221;no&#8221; type=&#8221;full_width&#8221; text_align=&#8221;left&#8221; box_shadow_on_row=&#8221;no&#8221;][vc_column][vc_column_text css=&#8221;&#8221;]End\u00fcstriyel enzim \u00fcreticisi olan Livzym Biyoteknoloji, yeni yat\u0131r\u0131m turunda 11 milyon dolar yat\u0131r\u0131m ald\u0131. Bu yat\u0131r\u0131ma biyoteknoloji alan\u0131n\u0131n \u00f6nemli k\u00fcresel oyuncular\u0131ndan Lallemand liderlik ederken, Evyap Holding, T\u00fcrk Telekom Ventures ve Startup\u0130st Ventures di\u011fer \u00f6nemli yat\u0131r\u0131mc\u0131lar oldu. Enzim, alternatif protein ve hassas fermantasyon kapasitesini artt\u0131rmak \u00fczere kullan\u0131lacak olan yat\u0131r\u0131mla birlikte, Livzym Biyoteknoloji\u2019nin de\u011ferlemesi 60 milyon dolara ula\u015ft\u0131.<\/p>\n<p>&nbsp;<\/p>\n<p>Biyoteknolojik y\u00f6ntemlerle enzim, alternatif proteinler ve postbiyotik alanlar\u0131nda, 4 farkl\u0131 disiplini b\u00fcnyesinde bar\u0131nd\u0131ran, d\u00fcnyadaki nadir \u015firketlerden birisi olarak konumlanan Livzym Biyoteknoloji, ger\u00e7ekle\u015ftirdi\u011fi yeni yat\u0131r\u0131m turuyla 11 milyon dolar yat\u0131r\u0131m ald\u0131.<\/p>\n<p>&nbsp;<\/p>\n<p>Biyoteknoloji alan\u0131nda d\u00fcnyan\u0131n \u00f6nde gelen \u015firketlerinden birisi olan Lallemand\u2019\u0131n stratejik yat\u0131r\u0131m orta\u011f\u0131 oldu\u011fu ve Evyap Holding, T\u00fcrk Telekom Ventures ve Startup\u0130st Ventures\u2019in kat\u0131ld\u0131\u011f\u0131 yat\u0131r\u0131m, Livzym\u2019in enzimlerin yan\u0131nda alternatif protein, hassas fermantasyon ve postbiyotik \u00fcretim kapasitesinin artt\u0131r\u0131lmas\u0131 i\u00e7in kullan\u0131lacak. Ayr\u0131ca Lallemand, Livzym\u2019in \u00fcretti\u011fi enzimlerin d\u00fcnya \u00e7ap\u0131nda sat\u0131\u015f\u0131n\u0131 da ger\u00e7ekle\u015ftirecek. Yeni yat\u0131r\u0131mla birlikte \u015firketin de\u011ferlemesi ise 60 milyon dolara ula\u015ft\u0131.<\/p>\n<p>&nbsp;<\/p>\n<p><b>\u201c\u00dclkemizi global \u00f6l\u00e7ekte bir \u00fcretim \u00fcss\u00fc haline getirmeyi hedefliyoruz\u201d<\/b><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Livzym Biyoteknoloji Kurucusu ve Genel M\u00fcd\u00fcr\u00fc Dr. Serdar Uysal, konuyla ilgili \u015funlar\u0131 s\u00f6yledi:<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>\u201cOnlarca sekt\u00f6rde teknolojik ara girdi olarak kullan\u0131lan ve kimyasallara alternatif \u00e7evreci bir \u00e7\u00f6z\u00fcm olan enzimi, yerli olarak \u00fcreten ilk ve tek biyoteknoloji \u015firketiyiz. Cumhurba\u015fkanl\u0131\u011f\u0131 Yat\u0131r\u0131m Ofisi ve di\u011fer ilgili kamu kurumlar\u0131m\u0131z\u0131n end\u00fcstriyel biyoteknolojiye verdikleri k\u0131ymetli desteklerin katk\u0131s\u0131yla, biyoteknolojide \u00fclkemizi global \u00f6l\u00e7ekte bir \u00fcretim \u00fcss\u00fc haline getirmek amac\u0131yla faaliyet g\u00f6steriyoruz. K\u00fcresel da\u011f\u0131t\u0131m a\u011f\u0131yla biyoteknoloji alan\u0131n\u0131n en \u00f6nemli oyuncular\u0131ndan olan Lallemand\u2019\u0131n liderli\u011finde, Evyap Holding, T\u00fcrk Telekom Ventures ve Startup\u0130st Ventures\u2019in kat\u0131l\u0131m\u0131yla ald\u0131\u011f\u0131m\u0131z yeni yat\u0131r\u0131m\u0131 enzim, alternatif protein teknolojileri ve hassas fermantasyon kapasitemizi artt\u0131rmak i\u00e7in \u00f6nemli bir ad\u0131m olarak de\u011ferlendiriyoruz. Lallemand\u2019\u0131n \u00fclkemize ve LIVZYM\u2019e duydu\u011fu g\u00fcvenin stratejik bir i\u015fbirli\u011fine d\u00f6n\u00fc\u015fmesinden memnuniyet duyuyoruz.\u201d[\/vc_column_text][vc_separator type=&#8221;transparent&#8221; up=&#8221;25&#8243; up_style=&#8221;px&#8221; down=&#8221;0&#8243; down_style=&#8221;px&#8221;][vc_column_text css=&#8221;&#8221;]<strong>Link:<\/strong> <a href=\"https:\/\/arhavi-haber.com.tr\/biyoteknolojide-yerli-uretime-stratejik-yatirim\/\" target=\"_blank\" rel=\"noopener\">https:\/\/arhavi-haber.com.tr\/biyoteknolojide-yerli-uretime-stratejik-yatirim\/<\/a>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>End\u00fcstriyel enzim \u00fcreticisi olan Livzym Biyoteknoloji, yeni yat\u0131r\u0131m turunda 11 milyon dolar yat\u0131r\u0131m ald\u0131. Bu yat\u0131r\u0131ma biyoteknoloji alan\u0131n\u0131n \u00f6nemli k\u00fcresel oyuncular\u0131ndan Lallemand liderlik ederken, Evyap Holding, T\u00fcrk Telekom Ventures ve Startup\u0130st Ventures di\u011fer \u00f6nemli yat\u0131r\u0131mc\u0131lar oldu. Enzim, alternatif protein ve hassas fermantasyon kapasitesini artt\u0131rmak \u00fczere kullan\u0131lacak olan yat\u0131r\u0131mla birlikte, Livzym Biyoteknoloji\u2019nin de\u011ferlemesi 60 milyon dolara ula\u015ft\u0131.<\/p>\n","protected":false},"author":1,"featured_media":21108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-20731","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/posts\/20731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/comments?post=20731"}],"version-history":[{"count":1,"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/posts\/20731\/revisions"}],"predecessor-version":[{"id":20732,"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/posts\/20731\/revisions\/20732"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/media\/21108"}],"wp:attachment":[{"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/media?parent=20731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/categories?post=20731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.livzym.com\/index.php\/wp-json\/wp\/v2\/tags?post=20731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}